Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
|
Device | EMDOGAIN GEL |
Generic Name | Biologic material, dental |
Regulation Number | 872.3930 |
Applicant | THE STRAUMANN COMPANY 60 Minuteman Road Andover, MA 01810 |
PMA Number | P930021 |
Supplement Number | S005 |
Date Received | 07/26/2000 |
Decision Date | 06/04/2002 |
Product Code |
NQA |
Advisory Committee |
Dental |
Supplement Type | Normal 180 Day Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement APPROVAL FOR THE REVISIONS TO THE PACKAGE INSERT AS LISTED BELOW BASED ON NEW DATA THAT HAS BEEN PRESENTED IN THIS PMA SUPPLEMENT. 1) INCLUSION OF THE FOLLOWING STATEMENT IN THE CLINICAL CONSIDERATIONS SECTION: "HISTOLOGICAL STUDIES HAVE DEMONSTRATED RESULTS RANGING FROM COMPLETE PERIODONTAL REGENERATION (NEWLY FORMED CEMENTUM, PERIODONTAL LIGAMENT, AND ALVEOLAR BONE) TO REPAIR INCLUDING NEW CONNECTIVE TISSUE ATTACHMENT (CONNECTIVE TISSUE ADAPTATION VIA NEW CEMENTUM) AND A NEW ATTACHMENT MEDIATED BY AN EPITHELIAL ATTACHMENT (LONG JUNCTIONAL EPITHELIUM). THE LONG-TERM STABILITY OF THE REGENERATED TISSUE HAS NOT BEEN ESTABLISHED. AS IN ANY PERIODONTAL SURGICAL THERAPY, DEFECT MORPHOLOGY, SURGICAL TECHNIQUE AND HOST RESPONSE ARE IMPORTANT PARAMETERS FOR SUCCESSFUL OUTCOMES." 2) INCLUSION OF THE FOLLOWING STATEMENTS IN THE CLINICAL CONSIDERATIONS SECTION: A) PATIENTS TEND TO REPORT LESS POST-SURGICAL DISCOMFORT; B) CLINICIANS HAVE REPORTED ON ENHANCED WOUND HEALING. |
|
|